This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Hikaru Nishimori: Innovator in Cancer Treatment
Introduction
Hikaru Nishimori is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the development of treatments for malignant tumors. His innovative work has led to the creation of a unique compound that holds promise for cancer therapy.
Latest Patents
Nishimori holds a patent for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, comprising a compound of formula (1). His work in this area is crucial for advancing cancer treatment options.
Career Highlights
Hikaru Nishimori is associated with Otsuka Pharmaceutical Company, Limited, where he continues to contribute to pharmaceutical innovations. His dedication to research and development has positioned him as a key figure in the fight against cancer.
Collaborations
Nishimori has worked alongside talented colleagues such as Takahiro Katoh and Masatoshi Iida. Their collaborative efforts have further enhanced the research and development of effective treatments.
Conclusion
Hikaru Nishimori's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical science and offers hope for patients battling malignant tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile